Synlait Milk Limited (ASX:SM1) has reported a 27% growth in its revenue for the FY20. The group has announced a revenue of $1,302 million and EBIDTA of $171.4 million for the FY20. The company show a rise of 46% in sales of its Lactoferrin product, followed by a 15% rise in sales of consumer-packaged powders.
The group has reported basic and diluted EPS of 41.95 cents and 41.85 cents respectively for FY20. The Group has not declared any dividend for FY20. The group also reported a pre-tax return on average capital employed to be at 12.6% for FY20 as compared to 18.3% in the previous year.
